GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Cash-to-Debt

Qlife Holding AB (OSTO:QLIFE) Cash-to-Debt : 0.50 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Qlife Holding AB's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.50.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Qlife Holding AB couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for Qlife Holding AB's Cash-to-Debt or its related term are showing as below:

OSTO:QLIFE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04   Med: 1.26   Max: 25.94
Current: 0.5

During the past 4 years, Qlife Holding AB's highest Cash to Debt Ratio was 25.94. The lowest was 0.04. And the median was 1.26.

OSTO:QLIFE's Cash-to-Debt is ranked worse than
73.37% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 1.99 vs OSTO:QLIFE: 0.50

Qlife Holding AB Cash-to-Debt Historical Data

The historical data trend for Qlife Holding AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Qlife Holding AB Cash-to-Debt Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Cash-to-Debt
0.97 1.28 15.56 0.28

Qlife Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.28 0.04 1.25 0.50

Competitive Comparison of Qlife Holding AB's Cash-to-Debt

For the Medical Devices subindustry, Qlife Holding AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Cash-to-Debt falls into.



Qlife Holding AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Qlife Holding AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Qlife Holding AB's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qlife Holding AB  (OSTO:QLIFE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Qlife Holding AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines